
Dutch health minister Bruno Bairns has called for a meeting with Swiss multinational Novartis after the multibillion-dollar firm introduced a …

Breast cancer patients in Scotland are set to receive an additional treatment option, as the Scottish Medicines Consortium announces its …

Congressman Elijah Cummings has launched an investigation into pharmaceutical pricing practices.The representative for Maryland’s 7th congressional district, on Monday requested …

AstraZeneca’s Sean Bohen has announced he will step down from his role as chief medical officer at the Anglo-Swedish drugmaker …

Kay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of …

Seqirus has made it known that its new cell-based seasonal influenza vaccine Flucelvax Tetra has been approved by the European …

Israeli multinational Teva Pharmaceuticals has agreed to pay $135 million after being accused of fraudulently inflating wholesale prices that went …

The British Government has come under fire over the appointment of former Tory MP, Nicola Blackwood, as a junior minister …

2018 was a strong year for European approvals according to the EMA; the regulator has recently released its Human medicines …

The Global Fund is seeking £11 billion worth of investment in an attempt to save 16 million lives in the …

Japanese pharma and biotech firm Kyowa Hakko Kirin is joining the growing trend of investing in artificial intelligence to bolster …

With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger merger was announced as US …

It’s only the second week of the New Year, and Johnson & Johnson has announced plans to hike the prices …

Senator Bernie Sanders has called on President Donald Trump to support new legislation aimed at cutting prices on prescription drugs. …

A new partnership between the UK and Japan will see medical researchers and scientists join forces, in advancing research into …

Roche subsidiary, Foundation Medicine, today announced the appointment of Roche’s senior vice president in global oncology, Cindy Perettie as the …

UK-based drug firm AstraZeneca has revealed it is set to shed more than 200 positions from its operations at two …

Scientists at the University of Texas Medical Branch (UTMB) in Galveston, Texas have developed a new experimental drug that protects …

It’s disappointing news for Novartis as NICE revealed that it had decided not to recommend Aimovig (erenumab) for routine NHS …

The FDA approved a record 971 generic drugs in the 2018 fiscal year, giving the go-ahead to 110 generics in …